Medidata Solutions (MDSO) PT Raised to $65 at Needham & Company

Go back to Medidata Solutions (MDSO) PT Raised to $65 at Needham & Company

Jefferies Downgrades Medidata Solutions (MDSO) to Hold

April 28, 2015 6:49 AM EDT

Jefferies downgraded Medidata Solutions (NASDAQ: MDSO) from Buy to Hold with a price target of $55.00 (from $52.00).

Analyst David Windley commented, "MDSO's strategy of growing its client list and growing within existing clients is advancing steadily, but not at such an eyepopping pace... More

Topeka Capital Downgrades Medidata Solutions (MDSO) to Hold

April 24, 2015 7:45 AM EDT

Topeka Capital downgraded Medidata Solutions (NASDAQ: MDSO) from Buy to Hold with a price target of $55.00 (from $48.00). The change is tied to valuation.

Analyst Eugene M. Mannheimer said, "While MDSO reiterated its full year outlook, our model suggests they... More

Medidata Solutions (MDSO) Tops Q1 EPS by 3c; Appoints New CFO

April 23, 2015 6:36 AM EDT

Medidata Solutions (NASDAQ: MDSO) reported Q1 EPS of $0.17, $0.03 better than the analyst estimate of $0.14. Revenue for the quarter came in at $92.4 million versus the consensus estimate of $91.05 million.

The company also announced that Rouven Bergmann is joining the company as Chief Financial Officer effective Monday, May 18, 2015. Bergmanns financial and operational experience managing a multibillion-dollar software business extends the breadth and depth of Medidatas leadership team. Medidata also reaffirmed today that there is no change to its 2015 financial guidance.

We are excited to have Rouvens proven financial leadership on... More